However, when the absolute concentrations of 12-month EGF and UMOD were adjusted for baseline EGF or UMOD, respectively, higher biomarker levels at 12 months were associated with a lower risk of DKD progression. The gene discussed is EGF; the disease is diabetic kidney disease.